Richard R. Deluca Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 9 months, 1 week ago
Richard R. Deluca has an estimated net worth of at least $67.1 million*, as of April 30, 2025. They own 160,173 shares of MRK stock. They have sold 552,851 shares of MRK stock since 2021, for an estimated $52.0 million.
Richard R. Deluca $MRK SEC Form 4 Insider Trading
Richard R. Deluca has filed a total of 7 insider trades in $MRK since 2021. Their most recent trade was a sale of 37,685 shares, made on Feb 06, 2026. Their largest trade was a sale of 164,557 shares, made on Oct 28, 2022. We estimate that they now own 160,173 shares of $MRK, worth an estimated $15.0 million.
Insider Trading at $MRK
There have been a total of 103 insider trades reported at $MRK since 2021, with 18,241 shares purchased and 5.3 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Steven Mizell, and Joseph Romanelli. The most recent trade was a sale of 5,000 shares reported by David Michael Williams (EVP,Chief Info&Digital Officer), made on Feb 06, 2026.
History of Insider Stock Trades by Richard R. Deluca
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRK
|
Sale | 37,685 | Feb 06, 2026 | Feb. 6, 2026, 5:08 p.m. |
MRK
|
Sale | 43,823 | Nov 08, 2023 | Nov. 9, 2023, 10:04 a.m. |
MRK
|
Sale | 66,163 | Apr 28, 2023 | May 2, 2023, 11:37 a.m. |
MRK
|
Sale | 75,436 | May 01, 2023 | May 2, 2023, 11:37 a.m. |
MRK
|
Sale | 164,557 | Oct 28, 2022 | Nov. 1, 2022, 5:04 p.m. |
MRK
|
Sale | 29,782 | Nov 04, 2021 | Nov. 4, 2021, 8 p.m. |
MRK
|
Sale | 135,405 | Oct 29, 2021 | Nov. 1, 2021, 8 p.m. |
$MRK Executives and Stock Owners with Insider Trades
-
Kenneth C Frazier, Executive Chair
-
Steven Mizell, EVP, Chief HR Officer
-
Joseph Romanelli, President, Human Health Int?l
-
Sanat Chattopadhyay, Exe V-P & Pres. MMD
-
Richard R. Deluca, EVP&Pres, Merck Animal Heallth
-
Johannes Jacobus Oosthuizen, President, U.S. Market
-
Robert M Davis, Chairman, CEO & President
-
Jennifer Zachary, EVP, General Counsel
-
David Michael Williams, EVP,Chief Info&Digital Officer
-
Rita A Karachun, Sr. VP Fince-Global Controller
-
Robert M Davis, CEO & President
-
Caroline Litchfield, EVP & CFO
-
Dean Y Li, Executive VP & President, MRL
-
Dalton E. Iii Smart, SVP Fin. - Global Controller
-
Cristal N Downing, Chief Comm. & Public Afrs Ofcr
-
Frank Clyburn, EVP & Pres ? Human Health
-
Chirfi Guindo, Chief Marketing Officer
-
Julie L. Gerberding, EVP, Chief Patient Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.